We are live on ! Find out more
UTMD icon

Utah Medical Products

62 hedge funds and large institutions have $107M invested in Utah Medical Products in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 15

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less funds holding

Funds holding: 6362 (-1)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

14% less capital invested

Capital invested by funds: $125M → $107M (-$17.4M)

Holders
62
Holders Change
-1
Holders Change %
-1.59%
% of All Funds
1.8%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
8
Increased
22
Reduced
15
Closed
9
Calls
Puts
Net Calls
Net Calls Change

UTMD Hedge Fund Activity: Q3 2014 in Review

62 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q3 2014, worth a combined $107M — down 14% from $125M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of UTMD and 8 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 22 added.

The largest buyer was American Century Companies, adding an estimated $2.06M. The largest seller was Bares Capital Management, exiting entirely with an estimated $15.6M sold.

  • 62 institutional investors held Utah Medical Products (UTMD) as of Q3 2014, down from 63 in Q2 2014.
  • Funds reported $107M of Utah Medical Products stock for Q3 2014, down 14% quarter-over-quarter.
  • 8 funds opened new Utah Medical Products positions in Q3 2014 and 9 closed out, a net change of -1 holder.
  • The largest Utah Medical Products buyer in Q3 2014 was American Century Companies, an estimated $2.06M added.
  • The largest Utah Medical Products seller in Q3 2014 was Bares Capital Management, an estimated $15.6M sold.

Based on aggregated 13F filings for Q3 2014.